Kiniksa Announces FDA Approval of Arcalyst (rilonacept) for Recurrent Pericarditis
HAMILTON, Bermuda, March 18, 2021 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company with a portfolio […]
HAMILTON, Bermuda, March 18, 2021 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company with a portfolio […] Hackensack Meridian Health CEO on COVID-19 vaccination process Bob Garrett, Hackensack Meridian Health CEO, speaks on vaccination progress in New […] (Reuters) – The U.S. Food and Drug Administration (FDA) on Friday approved Bristol-Myers Squibb’s cell-based gene therapy, Breyanzi, to treat […] November 25, 2020 — Under FDA law, approval of a new drug requires substantial evidence of effectiveness and a demonstration […] Fox News Flash top headlines for October 15 Fox News Flash top headlines are here. Check out what’s clicking on […] WEDNESDAY, Sept. 23, 2020 — Stricter guidelines for emergency authorization use of a vaccine against the new coronavirus could soon […] A targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced […] HOUSTON, TX / ACCESSWIRE / March 13, 2019 / Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical […] DUBLIN–(BUSINESS WIRE)–Dec. 27, 2018– Horizon Pharma plc (NASDAQ: HZNP) today announced the U.S. Food and Drug Administration (FDA) has approved […]Approval
Kiniksa Announces FDA Approval of Arcalyst (rilonacept) for Recurrent Pericarditis
Novavax COVID-19 vaccine could see approval by May, CEO says
FDA approves Bristol-Myers' gene therapy for white blood cell cancer
FDA: Remdesivir (Veklury) Approval for the Treatment of COVID-19 – The Evidence for Safety and Efficacy
Regeneron's Ebola drug gets first-ever FDA approval
Stricter Vaccine Approval Rules Coming From FDA
One lung cancer drug receives NHS England approval, while another is rejected
Moleculin Files with FDA for Expedited Approval Pathway for Annamycin
Horizon Pharma plc Announces FDA Approval to Expand the Age Range for Ravicti (glycerol phenylbutyrate) Oral Liquid to Include Newborns
Copyright © 2024